|Bid||9.60 x 1300|
|Ask||10.00 x 1000|
|Day's Range||9.30 - 9.83|
|52 Week Range||3.48 - 15.12|
|Beta (5Y Monthly)||0.59|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for VSTM
When discussing penny stocks to buy, no one should be under any illusion: this sector presents extreme dangers. And it’s not just about the severity and acceleration of losses when getting things wrong. Rather, the red ink can also lead to significant psychological distress. You must not invest more than you can comfortably lose. At the same time, penny stocks don’t represent a monolith. Yes, the vast majority of ideas can be considered wildly risky. And even the ones that have legitimate upside
Verastem could be angling for an accelerated approval of its ovarian cancer treatment, an analyst said Thursday as she upgraded VSTM stock.
It's nice to see the Verastem, Inc. ( NASDAQ:VSTM ) share price up 15% in a week. But will that repair the damage for...